BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 121505
Published online Aug 15, 2026. doi: 10.4239/wjd.121505
Figure 4
Figure 4 Risk stratification performance: Development vs temporal validation. The three-tier risk stratification system showed consistent 2-year recurrence rates between development and validation cohorts across low-risk (12.3% vs 14.1%), intermediate-risk (38.7% vs 41.2%), and high-risk (71.2% vs 68.7%) groups, with differences under 3 percentage points confirming model transportability.


Write to the Help Desk